Hunger hormones offer promising avenue for addiction treatment
Hormones that signal the body's state of hunger and fullness could be the key to new treatments for drug and alcohol addiction...
List view / Grid view
Hormones that signal the body's state of hunger and fullness could be the key to new treatments for drug and alcohol addiction...
It may be better to examine the urine and the blood of patients suspected of tumours of the plasma cells...
The expression of PI3Ky increases during infection by T.cruzi, providing an essential response controlling the parasite and avoiding inflammation...
Approach could improve understanding of immune system recovery in people treated for HIV infection...
A new system, pGENMi, could predict genomic features associated with drug responses, by identifying differences in gene expression...
IGF-1 activated by p38 may be a therapeutic target
A new malaria vaccine targets the protein PMIF, which is crucial in the life cycle of malaria parasites...
Early-stage research has uncovered a potential approach to treat one of the commonest causes of dementia and stroke in older people...
A new commentary by epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease...
New statistical method, ALFRED, could identify predisposition for cancers by using cancer genome data sets to identify risk variants.
Vascular Endothelial Growth Factor C (VEGF-C) could aid the repair and recovery of hearts after a heart attack, by enabling immune cells to clear dead and dying cells...
A 3D map of genetic interactions in CVD could aid researchers investigating future treatments for heat attacks, heart failure and heart rhythm disorders.
Scientists in the U.S. have identified what they believe to be the genesis of Alzheimer's disease – the precise point at which a healthy tau protein becomes toxic but has not yet formed deadly tangles in the brain. The finding opens up numerous avenues for treatment research.
Antibody mAb806 may be useful in treating aggressive forms of glioblastoma multiform...
Exclusive interview with Grace Macaulay - MedImmune released in the run up to the Immuno-Oncology Conference, taking place on the 26 - 27 September 2018 in London.